Abstract | BACKGROUND: Knowledge of autoimmune hemolytic anemia is rapidly increasing, especially on pathogenesis, associated disorders and aspects of transfusion immunology. New treatment options have emerged. MATERIAL AND METHOD: This review is based on selected publications, a non-systematic search in PubMed and the authors' own research. RESULTS: INTERPRETATION:
|
Authors | Sigbjørn Berentsen, Tatjana Sundic, Tor Hervig, Geir E Tjønnfjord |
Journal | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
(Tidsskr Nor Laegeforen)
Vol. 129
Issue 21
Pg. 2226-31
(Nov 05 2009)
ISSN: 0807-7096 [Electronic] Norway |
Vernacular Title | Autoimmun hemolytisk anemi. |
PMID | 19898570
(Publication Type: English Abstract, Journal Article, Review)
|
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Murine-Derived
- Autoantibodies
- Glucocorticoids
- Immunoglobulins, Intravenous
- Immunologic Factors
- Rituximab
- Prednisolone
|
Topics |
- Adult
- Anemia, Hemolytic, Autoimmune
(diagnosis, drug therapy, therapy)
- Antibodies, Monoclonal
(therapeutic use)
- Antibodies, Monoclonal, Murine-Derived
- Autoantibodies
(blood)
- Blood Transfusion
- Child
- Glucocorticoids
(therapeutic use)
- Humans
- Immunoglobulins, Intravenous
(therapeutic use)
- Immunologic Factors
(therapeutic use)
- Prednisolone
(therapeutic use)
- Rituximab
|